[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344760-105":59,"doc-detail-344760-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","clinical-characteristics-prognosis-and-fertility-outcomes-in-patients-with-simple-and-complex-endometrial-hyperplasia-comparative-analysis","Clinical characteristics, prognosis, and fertility outcomes in patients with simple and complex endometrial hyperplasia - Comparative analysis","","Clinical characteristics, hysteroscopic findings, prognosis, and fertility outcomes were compared between complex endometrial hyperplasia (CH) and simple endometrial hyperplasia (SH) in premenopausal patients. Medical records of 616 patients were collected from January 2012 to October 2023, with 419 SH and 197 CH cases, followed for at least 12 months and assessed for treatment plans and reproductive outcomes. Obesity, diabetes/insulin resistance, and PCOS increased CH risk, while gravidity ≥1 was protective. CH showed lower reversal and higher persistence, progression, recurrence, and canceration rates, with reduced live birth, and treatment with oral progesterone or LNG-IUS improved prognosis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinical-characteristics-prognosis-and-fertility-outcomes-in-patients-with-simple-and-complex-endometrial-hyperplasia-comparative-analysis/344760/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinical-characteristics-prognosis-and-fertility-outcomes-in-patients-with-simple-and-complex-endometrial-hyperplasia-comparative-analysis/344760.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What factors were identified as independent risk factors for complex endometrial hyperplasia (CH)?","Question",{"text":112,"@type":113},"Obesity, diabetes or insulin resistance, and polycystic ovary syndrome (PCOS) were identified as independent risk factors for CH. Gravidity ≥1 served as a protective factor for CH.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the prognosis of CH compare with SH?",{"text":117,"@type":113},"Compared with SH, the CH group had a significantly lower reversal rate and higher rates of persistence, progression, recurrence, and canceration. The live birth rate was also lower in CH than in SH.",{"name":119,"@type":110,"acceptedAnswer":120},"Which treatments were associated with improved prognosis in endometrial hyperplasia (EH)?",{"text":121,"@type":113},"Compared with no treatment, oral progesterone and a levonorgestrel-releasing intrauterine system (LNG-IUS) treatment were associated with improved prognosis for EH patients.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},344760,1790402812,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Archives of Gynecology and Obstetrics (2026) 313:87  \n[https://doi.org/10.1007/s00404-026-08356-9](https://doi.org/10.1007/s00404-026-08356-9)  \nClinical characteristics, prognosis, and fertility outcomes in patients with simple and complex endometrial hyperplasia: a comparative analysis  \nJiayu Wei1,2 · Hong Wang3 · Haiyun Wang1,2 · Yingmei Wang1,2 · Wenyan Tian1,2 · Huiying Zhang1,2  \nReceived: 12 June 2025 / Accepted: 31 January 2026 © The Author(s) 2026  \nAbstract  \nObjective To analyze the difference in general clinical data, clinical manifestations, hysteroscopic manifestations, prognosis and fertility between patients with complex endometrial hyperplasia (CH) and simple endometrial hyperplasia (SH) . Material and methods Collected the medical records of 616 premenopausal endometrial hyperplasia (EH) patients from January 2012 to October 2023, of which 419 SH patients and 197 CH patients were included in the study. All the patients were followed up at least 12 months, and asked about the follow-up treatment plan, review, pregnancy and reproductive outcome of the patients with reproductive needs.  \nResults Obesity (P = 0.044), having diabetes or insulin resistance (P = 0.032) and polycystic ovary syndrome (PCOS)(P \u003C 0.001) are risk factors for the occurrence of CH, while gravidity ≥ 1 (P = 0.045) is a protective factor for the occurrence of CH. Compared with the SH group, the reversal rate in the CH group was significantly lower (69.7% vs 83.6%, P\u003C 0.001), while the rate of persistence, progression, recurrence and canceration were higher (P \u003C 0.001) . Compared with no treatment, oral progesterone (P \u003C 0.001) and levonorgestrel-releasing intrauterine system (LNG-IUS) treatment (P \u003C 0.001) could improve the prognosis of patients with EH. The live birth rate of the CH group was obviously lower than that of the SH group ( 42.3% VS 61.1%, P = 0.038) . CH (OR = 2.68, 95%CI 1.12–6.39, P = 0.043) is an independent risk factor affecting the live birth rate of patients with EH.  \nConclusion Obesity, diabetes, insulin resistance, PCOS and nulligravidity are risk factors for patients with EH, while gravidity ≥ 1 served as a protective factor, particularly against CH. The type of hyperplasia is associated with a low live birthrate. The prognosis of EH patients is usually poor, with a low reversal rate and a long reversal time. However, LNG-IUScan improve their prognosis.  \nKeywords Endometrial hyperplasia · Obesity · Prognosis · Fertility · LNG-IUS  \nAbbreviations  \nEH Endometrial hyperplasia  \nCH Complex endometrial hyperplasia  \nJiayu Wei and Hong Wang equally contributed to this work.  \n* Huiying Zhang [huiying_zhang2020@126.com](huiying_zhang2020@126.com)  \nSH  \nAH  \nEIN  \nPCOS  \nAUB  \nSimple endometrial hyperplasia Atypical endometrial hyperplasia Endometrial intraepithelial neoplasia Polycystic ovary syndrome Abnormal uterine bleeding  \n1 Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, NO 154, Anshan Road, He Ping District, 300052 Tianjin, People’s Republic of China  \n2 Tianjin Key Laboratory of Female Reproductive Health and Eugenics, 300052 Tianjin, People’s Republic of China  \n3 Department of Gynecology and Obstetrics, Harbin Red Cross Central Hospital, Harbin 150078, Heilongjiang, People’s Republic of China  \nWhat does this study add ?  \nOur study identified obesity, diabetes/insulin resistance, and PCOS as independent risk factors for complex hyperplasia (CH), while gravidity ≥1 was protective factor. We added distinct hysteroscopic features in CH and early visual diagnosis. CH reduced live birth rates by 31% despite similar pregnancy rates, highlighting its impact on reproductive success. Our study included a large cohort and long follow-up over 12 months. Proposes long-term metabolic management (obesity/diabetes control) alongside LNG-IUS therapy to improve prognosis and prevent progressing to endometrial cancer.  \nIntroduction  \nEndometrial hyperplasia (EH) is a non-physiological, no","cbCaikNl1v21mduu","https://ap.wps.com/l/cbCaikNl1v21mduu","pdf",785356,"English","# Abstract\n## Objective\n## Material and methods\n## Results\n## Conclusion\n# Introduction\n# Material and methods","[{\"question\":\"What factors were identified as independent risk factors for complex endometrial hyperplasia (CH)?\",\"answer\":\"Obesity, diabetes or insulin resistance, and polycystic ovary syndrome (PCOS) were identified as independent risk factors for CH. Gravidity ≥1 served as a protective factor for CH.\"},{\"question\":\"How did the prognosis of CH compare with SH?\",\"answer\":\"Compared with SH, the CH group had a significantly lower reversal rate and higher rates of persistence, progression, recurrence, and canceration. The live birth rate was also lower in CH than in SH.\"},{\"question\":\"Which treatments were associated with improved prognosis in endometrial hyperplasia (EH)?\",\"answer\":\"Compared with no treatment, oral progesterone and a levonorgestrel-releasing intrauterine system (LNG-IUS) treatment were associated with improved prognosis for EH patients.\"}]","Clinical characteristics, prognosis, and fertility outcomes in patients with simple and complex endometrial hyperplasia - Comparative analysis | PDF",1790055154,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6b5089b97eb8e84417ff97d7d9e3e7b.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33524b6a15a43d857e82d6c3316a773e.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8ea79462cb7d2ccd380faaaaee46c92.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e995dfa8786e7a0ade00d2ba07b4b175.webp",980,1301]